Xiao B, Xu Y, Edwards S, Balakumar L, Dong X
Adv Funct Mater. 2025; 34(8).
PMID: 39990597
PMC: 11845219.
DOI: 10.1002/adfm.202307751.
Verster A, Salerno P, Valls R, Barrack K, Price C, McClure E
mBio. 2025; 16(3):e0342024.
PMID: 39945545
PMC: 11898760.
DOI: 10.1128/mbio.03420-24.
De-la-Rosa-Martinez D, Villasenor-Echavarri R, Vilar-Compte D, Mosqueda-Larrauri V, Zinser-Peniche P, Blumberg S
Gut Pathog. 2025; 17(1):6.
PMID: 39871276
PMC: 11773978.
DOI: 10.1186/s13099-024-00674-0.
Markulic J, Fuller M
BMJ Open. 2025; 15(1):e092209.
PMID: 39855646
PMC: 11759219.
DOI: 10.1136/bmjopen-2024-092209.
Mares C, Sasaran M, Marginean C
Nutrients. 2025; 16(24.
PMID: 39770940
PMC: 11679674.
DOI: 10.3390/nu16244319.
Normalization of Cystic Fibrosis Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of Cystic Fibrosis Mice.
Scull C, Hu Y, Jennings S, Wang G
Cell Mol Gastroenterol Hepatol. 2024; 19(2):101424.
PMID: 39510500
PMC: 11720009.
DOI: 10.1016/j.jcmgh.2024.101424.
Species- and subspecies-level characterization of health-associated bacterial consortia that colonize the human gut during infancy.
Minot S, Mayer-Blackwell K, Fiore-Gartland A, Johnson A, Self S, Bhatti P
Gut Microbes. 2024; 16(1):2414975.
PMID: 39428758
PMC: 11497992.
DOI: 10.1080/19490976.2024.2414975.
Recommended Tool Compounds for Modifying the Cystic Fibrosis Transmembrane Conductance Regulator Channel Variants.
Han X, Li D, Zhu Y, Schneider-Futschik E
ACS Pharmacol Transl Sci. 2024; 7(4):933-950.
PMID: 38633590
PMC: 11019735.
DOI: 10.1021/acsptsci.3c00362.
Scoring Abdominal Symptoms in People with Cystic Fibrosis.
Tabori H, Barucha A, Zagoya C, Duckstein F, Dunay G, Sadrieh P
J Clin Med. 2024; 13(6).
PMID: 38541878
PMC: 10971656.
DOI: 10.3390/jcm13061650.
The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review.
Davis T, Miller A, Hachem C, Velez C, Patel D
Transl Gastroenterol Hepatol. 2024; 9:10.
PMID: 38317748
PMC: 10838618.
DOI: 10.21037/tgh-23-59.
Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.
Anton-Paduraru D, Murgu A, Bozomitu L, Mindru D, Iliescu Halitchi C, Trofin F
Diagnostics (Basel). 2024; 14(2).
PMID: 38275475
PMC: 10814426.
DOI: 10.3390/diagnostics14020228.
An medium for modeling gut dysbiosis associated with cystic fibrosis.
Barrack K, Hampton T, Valls R, Surve S, Gardner T, Sanville J
J Bacteriol. 2024; 206(1):e0028623.
PMID: 38169295
PMC: 10810206.
DOI: 10.1128/jb.00286-23.
Strain-level characterization of health-associated bacterial consortia that colonize the human gut during infancy.
Minot S, Mayer-Blackwell K, Fiore-Gartland A, Johnson A, Self S, Bhatti P
medRxiv. 2024; .
PMID: 38168439
PMC: 10760300.
DOI: 10.1101/2023.12.16.23300077.
Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study.
Asensio-Grau A, Heredia A, Garcia-Hernandez J, Cabrera-Rubio R, Masip E, Ribes-Koninckx C
Pediatr Res. 2023; 95(6):1519-1527.
PMID: 38092964
DOI: 10.1038/s41390-023-02944-0.
A Gastroenterologist's Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care.
Patel D, Baliss M, Saikumar P, Numan L, Teckman J, Hachem C
Int J Mol Sci. 2023; 24(21).
PMID: 37958749
PMC: 10648514.
DOI: 10.3390/ijms242115766.
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R, Santos C, Hanson L, Ng C, Major G, Smyth A
Microbiol Spectr. 2023; :e0117523.
PMID: 37607068
PMC: 10581179.
DOI: 10.1128/spectrum.01175-23.
Development of the intestinal microbiome in cystic fibrosis in early life.
Price C, Hampton T, Valls R, Barrack K, OToole G, Madan J
mSphere. 2023; 8(4):e0004623.
PMID: 37404016
PMC: 10449510.
DOI: 10.1128/msphere.00046-23.
Genome Editing for Cystic Fibrosis.
Wang G
Cells. 2023; 12(12).
PMID: 37371025
PMC: 10297084.
DOI: 10.3390/cells12121555.
Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO.
Banaszak M, Gorna I, Wozniak D, Przyslawski J, Drzymala-Czyz S
Microorganisms. 2023; 11(3).
PMID: 36985147
PMC: 10052891.
DOI: 10.3390/microorganisms11030573.
Mucin glycans drive oral microbial community composition and function.
Wu C, Wheeler K, Carcamo-Oyarce G, Aoki K, McShane A, Datta S
NPJ Biofilms Microbiomes. 2023; 9(1):11.
PMID: 36959210
PMC: 10036478.
DOI: 10.1038/s41522-023-00378-4.